Interestingly, MYCN negative correlated genes are significantly enriched of different immune system pathways in both NB cohort 1 (E-MTAB-1781) and NB cohort 2 (TARGET) (Figure 1A). This evidence concerns the gene MYCN and neuroblastoma.